tiprankstipranks
Adicet Bio (ACET)
NASDAQ:ACET

Adicet Bio (ACET) Income Statement

529 Followers

Adicet Bio Income Statement

Last quarter (Q4 2023), Adicet Bio's total revenue was $177.00K, an increase of Infinity% from the same quarter last year. In Q4, Adicet Bio's net income was $-68.41M. See Adicet Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 714.00K$ 714.00K$ 24.99M$ 9.73M$ 17.90M$ 995.00K
Cost of Revenue
------
Gross Profit
$ 714.00K$ 714.00K$ 24.99M$ 9.73M--
Operating Expense
$ 152.04M$ 152.04M$ 97.54M$ 71.16M$ 57.09M$ 32.38M
Operating Income
$ -152.04M$ -152.04M$ -72.55M$ -61.43M$ -39.19M$ -31.39M
Net Non Operating Interest Income Expense
$ 9.95M$ 9.95M$ 3.68M$ -85.00K$ 651.00K$ 938.00K
Other Income Expense
$ 573.00K$ 573.00K$ 919.00K$ 606.00K$ -953.00K$ 2.33M
Pretax Income
$ -142.66M$ -142.66M$ -69.79M$ -62.12M$ -39.49M$ -28.12M
Tax Provision
---$ -125.00K$ -2.81M$ 19.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -142.66M$ -142.66M$ -69.79M$ -62.00M$ -36.68M$ -28.14M
Basic EPS
$ -3.31$ -3.31$ -1.70$ -2.00$ -5.01$ -1.44
Diluted EPS
$ -3.31$ -3.31$ -1.70$ -2.00$ -5.01$ -1.44
Basic Average Shares
$ 172.17M$ 43.04M$ 41.08M$ 30.95M$ 7.32M$ 19.59M
Diluted Average Shares
$ 172.17M$ 43.04M$ 41.08M$ 30.95M$ 7.32M$ 19.59M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 152.04M$ 152.04M$ 97.54M$ 71.16M$ 57.09M$ 32.38M
Net Income From Continuing And Discontinued Operation
$ -142.66M$ -142.66M$ -69.79M$ -62.00M$ -36.68M$ -28.14M
Normalized Income
$ -65.01M---$ -36.68M$ -28.14M
Interest Expense
----$ 134.00K$ 0.00
EBIT
$ -142.63M$ -142.63M$ -69.71M$ -61.95M$ -39.36M$ -28.12M
EBITDA
$ -136.50M$ -136.50M$ -67.04M$ -60.23M$ -38.13M$ -26.88M
Currency in USD

Adicet Bio Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis